| # | Drug | Count |
|---|---|---|
| 0 | HUMAN IMMUNOGLOBULIN G | 4 |
| 1 | ABACAVIR | 2 |
| 2 | ABACAVIR SULFATE | 2 |
| 3 | ATAZANAVIR | 2 |
| 4 | LAMIVUDINE | 2 |
| 5 | LAMIVUDINE ORAL | 2 |
| 6 | RITONAVIR | 1 |
| 7 | RITONAVIR 100 MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ABACAVIR SULFATE | 2 | 0.0002 |
| 1 | HUMAN IMMUNOGLOBULIN G | 4 | 0.0002 |
| 2 | ATAZANAVIR | 2 | 0.0001 |
| 3 | LAMIVUDINE | 2 | 0.0001 |
| 4 | RITONAVIR 100 MG | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 8 | 0.0004 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |